Health Care & Life Sciences » Biotechnology | Ampliphi Biosciences Corp.

Ampliphi Biosciences Corp. | Ownership

Companies that own Ampliphi Biosciences Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Empery Asset Management LP
1,000,000
6.07%
929,078
1.19%
01/10/2018
The Vanguard Group, Inc.
212,113
1.29%
113,760
0%
06/30/2018
Renaissance Technologies LLC
162,960
0.99%
37,600
0%
06/30/2018
Geode Capital Management LLC
72,911
0.44%
35,462
0%
06/30/2018
PanAgora Asset Management, Inc.
44,130
0.27%
19,491
0%
06/30/2018
Acadian Asset Management LLC
40,815
0.25%
-36,465
0%
06/30/2018
G1 Execution Services LLC
31,925
0.19%
31,925
0%
06/30/2018
Citadel Advisors LLC
28,121
0.17%
28,121
0%
06/30/2018
IFP Advisors, Inc.
23,500
0.14%
0
0%
06/30/2018
Northern Trust Investments, Inc.
20,754
0.13%
8,091
0%
06/30/2018

About Ampliphi Biosciences

View Profile
Address
3579 Valley Centre Drive
San Diego California 92130
United States
Employees -
Website http://www.ampliphibio.com
Updated 09/14/2018
AmpliPhi Biosciences Corp. operates as a biopharmaceutical company. It engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company was founded in March 1989 and is headquartered in San Diego, CA.